Earticle

초록

영어

Therapeutic duplication of prescriptions is the most frequently reported inappropriate drug use in Korea. To prevent significant problems during drug prescribing and dispensing, prospectively, development of standard including drug lists considered as therapeutic duplications for the prioritized drug classes first would be necessary. This study was aimed to analyze frequent drug classes of therapeutic duplications by healthcare providers in clinical practice settings. National health claims data for drug review and reimbursement (1,426,065 prescriptions dated March 19, 2008) were analyzed. Therapeutic duplication was defined as the prescription including more than 2 ingredients belonging to the same KFDA drug classification numbers that considered to have therapeutic similarities. The following 3 drug classes were mostly frequent therapeutic duplication classes: 114 anti-pyretics, analgesics and anti-inflammatory drugs; 117 drugs for psycho- nervous system; 141 Antihistamines. About 3.5% of overall prescriptions analyzed showed therapeutic duplications. This result might be starting step to develop DUR therapeutic duplication standard.

목차

연구방법
  분석대상 데이타베이스
  치료중복의 정의
  분석방법
  연구결과
  다빈도 처방 의약품 약효군 및 다빈도 치료중복 의약품약효군
 고찰 및 결론
 참고문헌

키워드

저자

• 손현순 [ Hyun Soon Sohn | 숙명여자대학교 약학대학 ]
• 이영숙 [ Young Sook Lee | 원광대학교 약학대학 ]
• 최경업 [ Kyung Eob Choi | 건강보험심사평가원 ]
• 신현택 [ Hyun Taek Shin | 건강보험심사평가원 ] Correspondence to

참고문헌

발행기관

간행물

표지보기 관심저널 등록

• 간행물명

  한국임상약학회지 [Korean Journal of Clinical Pharmacy]

• 간기

  계간

• pISSN

  1226-6051

• 수록기간

  1991~2026

• 등재여부

  KCI 등재

• 십진분류

  KDC 518 DDC 615